Renal transplantation for APS patients with ESKD is associated wi

Renal transplantation for APS patients with ESKD is associated with increased risk of systemic or allograft thrombosis or TMA.[22, 23] Here we present a transplant recipient with SLE and APS who developed acute allograft dysfunction associated with TMA, despite perioperative anticoagulation. A 26-year-old non-smoking, nulliparous female presented with three

weeks of wrist and finger pain, rash involving the face and chest, mouth ulcers, fevers, weight loss and lethargy. Blood pressure was 130/70 mmHg PF-01367338 cost and dipstick urinalysis revealed protein (2+) and blood (3+). Urine microscopy showed dysmorphic erythrocytes (470 × 106/L) and leukocytes (150 × 106/L), with no bacterial growth, and 24-hour urinary protein excretion was 2.1 g/day. Full blood count, serum electrolytes and liver function tests were unremarkable. Immunology

studies (Table 2) revealed a positive antinuclear antibody (ANA 1/640 titre in a homogeneous pattern) and anti-double-stranded DNA (dsDNA). Serum complement C3 and C4 were low. LA was positive with a prolonged activated partial thromboplastin time (APTT) that failed to correct with normal serum and confirmation of phospholipid dependence through platelet neutralization. aCL antibodies were strongly positive (anti-β2-GP1 antibodies were not tested). Treatment for SLE was commenced with oral prednisolone and hydroxychloroquine. Subsequently the patient presented with a lower limb DVT, which combined with the persistently positive LA and high-titre aCL antibodies led to a diagnosis of APS. Anticoagulation was begun with low molecular weight Proteasome inhibitor heparin (LMWH) followed by warfarin, later replaced by aspirin. The patient remained well without medical review for a number of years before returning with a systemic flare of

SLE and renal involvement. Renal biopsy at this time revealed diffuse proliferative lupus nephritis (WHO class IV-g/a). Administration of high-dose steroids, mycophenolate mofetil, and rituximab was followed by a fall in the dsDNA titre and normalization of serum complement levels, but LA and aCL antibodies remained positive. Anaemia (haemoglobin 95 g/L) and thrombocytopenia (platelet count 65 × 109/L) this website were present without red cell fragmentation. Renal function deteriorated leading to dialysis dependence, and a further biopsy showed quiescent lupus nephritis with superimposed TMA. Glomeruli were variably haemorrhagic or ischaemic, many showing fibrin thrombi at the vascular pole and red cell fragments in capillary lumina. Electron microscopy revealed markedly swollen endothelial cells and abundant subendothelial flocculant material. Assays for reduced ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 domains, number 13) activity, anti-ADAMTS13 autoantibodies, complement regulatory gene mutations and anti-factor H autoantibodies were not performed.

Related posts:

  1. Bilateral renal robotic procedures at the same setting can be acc
  2. Jansen et al observed a progressive decline in left renal functi
  3. mTOR Inhibitors Dovitinib for individuals undergoing autologous stem cell transplantation
  4. A spectrum of treatment (from bleeding to liver transplantation [
  5. Unlike WT mice and hnRNP F Tg mice, renal structural harm was evi
This entry was posted in Antibody. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>